Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis

Comparision of the efficacy and safety between Secukinumab and Adalimumab in the treatment of the moderate to severe plaque psoriasis

Objective To evaluate the efficacy and safety of Secukinumab versus Adalimumab in the treatment of the moderate to severe plaque psoriasis. Methods A total of 90 patients with moderate to severe psoriasis were randomly divided into three groups: Secukinumab group (30 patients), Adalimumab (29 patien...

Full description

Bibliographic Details
Main Authors: Dandan HU, Peimiao ZHANG
Format: Article
Language:zho
Published: editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology 2023-06-01
Series:Pifu-xingbing zhenliaoxue zazhi
Subjects:
secukinumab
adalimumab
conventional therapy
moderate to severe plaque psoriasis
Online Access:http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.03.011

Internet

http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.03.011

Similar Items